首頁 > 市場調查報告書 > 醫療設備

導管循環系統

市場調查報告書

商品編碼

1764955

亞太地區外周栓塞線圈市場預測（2031年）-區域分析-按類型、材料和應用

Asia Pacific Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis - by Type, Material, and Application

出版日期: 2025年04月14日 | 出版商:

The Insight Partners | 英文 126 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

2023 年亞太周邊栓塞線圈市值為 1.3845 億美元，預計到 2031 年將達到 2.0452 億美元；預計 2023 年至 2031 年的複合年成長率為 5.0%。

栓塞線圈應用範圍不斷擴大，推動亞太外周栓塞線圈市場發展

周邊栓塞線圈市場的公司持續專注於新產品的發布和市場核准，這有助於他們提升銷售額。以下列舉了外周栓塞線圈市場的一些值得關注的發展。 2024年1月，國家藥品監督管理局批准了由Zylox-Tonbridge醫療技術有限公司生產的ZYLOX Phoenix外周可分離纖維彈簧圈栓塞系統。周邊血管介入是此栓塞線圈系統最常見的應用。內臟動脈瘤的栓塞治療、腹主動脈瘤的內漏管理、咯血和動靜脈瘺是該系統的其他重要臨床應用，其安全性和有效性得到了國際認可。 2022年4月，波士頓科學公司（Boston Scientific Corporation）的EMBOLD纖維可分離彈簧圈（Fibered Detachable Coil）獲得美國食品藥物管理局（FDA）的510(k)上市許可。本產品旨在阻斷或降低周邊血管的血流速度。波士頓科學公司介入腫瘤學產品組合的最新成員旨在用於各種栓塞手術，這些手術必然是微創治療，旨在阻斷一條或多條血管以阻塞或減少血流。 EMBOLD纖維可分離彈簧圈採用由三個彈簧圈組成的單一平台，方便醫師根據不同患者的需求和解剖結構進行治療。因此，預計新產品的開發和市場批准將為預測期內周邊栓塞彈簧圈市場的成長創造機會。

亞太地區外周栓塞線圈市場概況

亞太地區外周栓塞線圈市場細分為中國、印度、日本、韓國、澳洲和亞太其他地區。該地區市場的成長歸因於醫療基礎設施的不斷發展，以及歐洲各國腹主動脈瘤、急性胃腸道出血 (AGIB) 和腫瘤的發生率較高。根據 2022 年 4 月發表在《BMC Public Health》上的一篇文章，中國主動脈瘤的疾病負擔從 1990 年到 2020 年急劇增加，男性、老年人口和西部省份居民的死亡率更高。靜脈曲張是一種常見疾病，影響 30% 的印度人口，尤其是女性。病情會隨著時間的推移而發展，導致出血、凝血和潰瘍等併發症，影響患者的生活品質。靜脈曲張患者極易發生深部靜脈血栓形成，因為靜脈淤滯和損傷常導致淺靜脈炎，淺靜脈炎可經由穿孔動脈擴散並進入深部靜脈系統。

日本國立癌症中心數據顯示，2022年日本新增腫瘤病例超過100萬，腫瘤相關死亡病例超過38萬400例。大腸直腸癌、胃癌、肺癌和攝護腺癌是日本最常見的癌症，佔所有癌症病例的45%以上。日本前列腺癌的診斷數量在過去十年中增加了1.8倍。大量人被診斷出患有由各種可能的風險因素（最明顯的是人口老化）引起的癌症，前列腺癌病例正在快速成長。上消化道出血（AGIB）是一種常見的急症，發病率和死亡率都很高。它分為上消化道出血（UGIB）和下消化道出血（LGIB），兩者決定了患者的評估和治療方案。根據昆士蘭州政府統計，在澳大利亞，UGIB每年影響每10萬人中50-150人，死亡率為6-8%。同一來源也指出，目前尚無澳洲LGIB病例的資料。根據美國國立衛生研究院（NIH）發表的一篇文章，2023年，創傷性損傷在韓國主要死因中排名第三，佔總死亡率的9.2%。創傷在年輕人中更為常見，男性報告的病例數是女性的兩倍。韓國可預防的院內創傷死亡率高於其他已開發國家，介於5%至10%之間。

亞太地區周邊栓塞線圈市場收入及預測（2031 年）（百萬美元）

亞太外周栓塞線圈市場細分

亞太地區外周栓塞線圈市場按類型、材料、應用和國家分類。

根據類型，亞太地區周邊栓塞線圈市場分為可分離線圈和可推動線圈。 2023年，可分離線圈佔據了較大的市佔率。

就材質而言，亞太地區周邊栓塞線圈市場主要分為鉑金、鉑金水凝膠以及鉑鎢合金。鉑金在2023年佔據了最大的市場佔有率。

根據應用，亞太地區周邊栓塞線圈市場細分為出血和創傷、畸形、腫瘤、內臟動脈瘤、II型內漏和靜脈曲張。出血和創傷領域在2023年佔據了最大的市場。

根據國家/地區，亞太地區周邊栓塞線圈市場細分為中國、日本、印度、澳洲、韓國和亞太其他地區。 2023年，中國佔據了亞太地區周邊栓塞線圈市場佔有率的主導地位。

Medtronic Plc；Penumbra, Inc.；Balt；Boston Scientific Corp；Cook Medical Holdings LLC；Wallaby Medical；Spartan Micro Inc.；ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO.; LTD.；Terumo Corp；以及 NeuroSafe Medical Co. Ltd. 是亞太地區外周栓塞線圈市場領先的公司。

Companies operating in the peripheral embolization coils market constantly focus on new product launches and marketing approval, which helps them improve their sales. A few of the noteworthy developments in the peripheral embolization coils market are mentioned below. In January 2024, the National Medical Products Administration provided marketing approval for the ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System manufactured by Zylox-Tonbridge Medical Technology Co Ltd. Peripheral vascular intervention is the most prevalent application of this embolization coil system. Embolization treatment of visceral aneurysms, endoleak management of abdominal aortic aneurysms, hemoptysis, and arteriovenous fistula are the other important clinical applications of the system, which are internationally recognized for their safety and efficacy. In April 2022, Boston Scientific Corporation received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil designed to block or reduce the blood flow rate in the peripheral vasculature. The newest addition to Boston Scientific's interventional oncology portfolio was designed for use in various embolization procedures, necessarily minimally invasive treatments intended to block one or more blood vessels to obstruct or reduce blood flow. The EMBOLD Fibered Detachable Coil features a single platform consisting of three coils, making it simpler for physicians to address various patient needs and anatomies. Thus, new product developments and marketing approvals are anticipated to create opportunities for growth of the peripheral embolization coils market during the forecast period.

Asia Pacific Peripheral Embolization Coils Market Overview

The Asia Pacific peripheral embolization coil market is segmented into China, India, Japan, South Korea, Australia, and Rest of Asia Pacific. Market growth in this region is ascribed to the continuously advancing healthcare infrastructure, and the significant incidence of abdominal aortic aneurysms, acute gastrointestinal bleeding (AGIB), and tumors in different European countries. According to an article published in BMC Public Health in April 2022, the disease burden of aortic aneurysms in China increased dramatically from 1990 to 2020, with greater mortality rates among men, elderly populations, and residents of western provinces. Varicose veins, a common condition, affect 30% of the Indian population, particularly women. Conditions can develop over time, resulting in complications such as bleeding, clotting, and ulceration that impact the quality of life of patients. Patients with varicose veins are highly susceptible to developing deep vein thrombosis because venous stasis and damage often result in superficial phlebitis, which can spread through perforating arteries and enter the deep venous system.

According to the National Cancer Centre of Japan, the country recorded more than 1million new tumor cases and 380,400 tumor-related deaths in 2022. Colorectal, stomach, lung, and prostate tumors are the most frequent cancers in Japan, accounting for over ~45% of all cancer cases. Prostate cancer diagnoses in Japan have increased 1.8 times in the last decade. A vast number of people are being diagnosed with cancer caused by a variety of possible risk factors, most notably population aging, and the cases of prostate cancer are surging at a rapid pace. AGIB is a common emergency condition with high morbidity and death rates. It is divided into upper gastrointestinal bleeding (UGIB) and lower gastrointestinal bleeding (LGIB), which determine the course of patient evaluation and treatment. According to the Queensland Government, in Australia, UGIB affects 50-150 individuals per 100,000 people per year, with a 6-8% fatality rate. The same source also states that there is no data is available on LGIB cases in Australia. According to an article published by NIH, in 2023, traumatic injuries ranked third among the leading causes of death in South Korea, accounting for 9.2% of the total mortality. Trauma is more common in younger people, and the cases reported in men are twice those in women. South Korea has a higher preventable in-hospital trauma fatality rate than other developed countries, which ranges from 5% to 10%.

Asia Pacific Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Peripheral Embolization Coils Market Segmentation

The Asia Pacific peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the Asia Pacific peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the Asia Pacific peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the Asia Pacific peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the Asia Pacific peripheral embolization coils market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO.; LTD.; Terumo Corp; and NeuroSafe Medical Co. Ltd. are among the leading companies operating in the Asia Pacific peripheral embolization coils market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Asia Pacific Peripheral Embolization Coils Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Aortic Aneurysm
- 4.1.2 Increase in Incidence of Cancer
4.2 Market Restraints
- 4.2.1 Complications Arising During or After Embolization
4.3 Market Opportunities
- 4.3.1 Expanding Range of Applications of Embolization Coils
4.4 Future Trends
- 4.4.1 Growing Importance of Packing Density
4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - Asia Pacific Analysis

5.1 Asia Pacific Peripheral Embolization Coils Market Overview
5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
5.3 Peripheral Embolization Coils Market Forecast Analysis
5.4 Peripheral Embolization Coils Market: Company Positioning

6. Asia Pacific Peripheral Embolization Coils Market Analysis - by Product Type

6.1 Overview
6.2 Detachable Coil
- 6.2.1 Overview
- 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Pushable Coil
- 6.3.1 Overview
- 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Peripheral Embolization Coils Market Analysis - by Material

7.1 Overview
7.2 Platinum
- 7.2.1 Overview
- 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Platinum & Hydrogel
- 7.3.1 Overview
- 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Platinum Tungsten Alloy
- 7.4.1 Overview
- 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Peripheral Embolization Coils Market Analysis - by Application

8.1 Overview
8.2 Bleedings & Trauma
- 8.2.1 Overview
- 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Malformations
- 8.3.1 Overview
- 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Tumors
- 8.4.1 Overview
- 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Visceral Aneurysms
- 8.5.1 Overview
- 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Endoleak Type II
- 8.6.1 Overview
- 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Varicose Veins
- 8.7.1 Overview
- 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Peripheral Embolization Coils Market - Country Analysis

9.1 Asia Pacific: Market Overview
- 9.1.1 Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 9.1.1.1 China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.1.1 China: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.1.2 China: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.1.3 China: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.2 Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.2.1 Japan: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.2.2 Japan: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.2.3 Japan: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.3 India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.3.1 India: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.3.2 India: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.3.3 India: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.4 Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.4.1 Australia: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.4.2 Australia: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.4.3 Australia: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.5 South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.5.1 South Korea: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.5.2 South Korea: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.5.3 South Korea: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.6 Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.6.1 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.6.2 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.6.3 Rest of Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Peripheral Embolization Coils Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Penumbra, Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Balt
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Boston Scientific Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Cook Medical Holdings LLC
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Wallaby Medical
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Spartan Micro Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Terumo Corp
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 NeuroSafe Medical Co. Ltd
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms

簡介目錄圖表

List Of Tables

Table 1. Asia Pacific Peripheral Embolization Coils Market Segmentation
Table 2. Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Table 3. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 4. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 5. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 6. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 7. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 8. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 9. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 10. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 11. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 12. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 13. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 14. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 15. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 16. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 17. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 18. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Product Type
Table 19. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Material
Table 20. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million) - by Application
Table 21. Recent Inorganic Growth Strategies in the Peripheral Embolization Coils Market
Table 22. Recent Organic Growth Strategies in the Peripheral Embolization Coils Market
Table 23. Glossary of Terms, Peripheral Embolization Coils Market

List Of Figures

Figure 1. Asia Pacific Peripheral Embolization Coils Market Segmentation, by Country
Figure 2. Peripheral Embolization Coils Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
Figure 5. Company Positioning
Figure 6. Peripheral Embolization Coils Market Share (%) - by Product Type (2023 and 2031)
Figure 7. Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 8. Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 9. Peripheral Embolization Coils Market Share (%) - by Material (2023 and 2031)
Figure 10. Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 11. Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 12. Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 13. Peripheral Embolization Coils Market Share (%) - by Application (2023 and 2031)
Figure 14. Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 15. Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 16. Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 17. Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 18. Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 19. Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 20. Asia Pacific: Peripheral Embolization Coils Market, by Key Country - Revenue (2023) (US$ Million)
Figure 21. Asia Pacific: Peripheral Embolization Coils Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 22. China: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 23. Japan: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 24. India: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 25. Australia: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 26. South Korea: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 27. Rest of Asia Pacific: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
Figure 28. Growth Strategies in the Peripheral Embolization Coils Market